SNOA · Sonoma Pharmaceuticals, Inc.
$1.14
+0.00 (+0.00%)
At close · Jul 27
Market Cap
$5.46M
Shares
4.79M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Amy Trombly | CEO | $726,543 |
| Bruce Thornton | COO | $658,568 |
| Jerry Dvonch | CFO | $307,458 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Amy Trombly | CEO | $559,939 |
| Bruce Thornton | COO | $484,653 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Amy Trombly | CEO | $643,000 |
| Bruce Thornton | COO | $554,000 |
| Jerry Dvonch | CFO | $427,000 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Amy Trombly | CEO | $580,000 |
| Bruce Thornton | COO | $517,000 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Bubba Sandford | CEO | $371,551 |
| Bruce Thornton | COO | $366,000 |
| John Dal Poggetto | CFO | $284,186 |
| Amy Trombly | CEO | $238,892 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Bubba Sandford | CEO | $430,417 |
| Bruce Thornton | COO | $310,508 |